Phase I study of low-dose cyclophosphamide and recombinant interleukin-2 for the treatment of advanced cancer

Christopher J. Verdi, Charles W. Taylor, Marilyn K. Croghan, Patricia Dalke, Frank L. Meyskens, Evan M. Hersh

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of low-dose cyclophosphamide and recombinant interleukin-2 for the treatment of advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences